Migrastatics: an overview of the current scenario and future cancer treatments - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Migrastatics: A Comprehensive Review of Present Developments and Future Directions in Cancer Therapy

  • By

  • Irene Olivas-Cano

  • M. Angeles Juanes

  • September 2, 2026

Share

  • 1

    Metastasis is the leading cause of cancer-related deaths, necessitating the development of therapies to suppress metastatic spread.

  • 2

    Migrastatics are agents designed to disrupt cellular invasiveness by targeting the cytoskeleton, impacting cell motility and invasive processes.

  • 3

    The toxicity associated with migrastatics has hindered their clinical application, despite their potential to prevent cancer relapse.

  • 4

    Metastasis involves a dynamic process of dissemination, dormancy, and colonization, complicating therapeutic management.

  • 5

    Cytoskeletal dynamics are crucial for metastasis regulation, enabling cancer cells to adapt and migrate through various environments.

Original Source(s)

Related Content